- Exchange: KOSDAQ
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Snapshot for Celltrion Inc (068270)
| Open: | 31,350 | Day's Range: | 31,250 - 32,000 | Volume: | 497,145 |
|---|---|---|---|---|---|
| Previous Close: | 31,600 | 52wk Range: | 26,650 - 60,435 | 1-Yr Rtn: | -40.00% |
Key Statistics for 068270
| Current P/E Ratio (ttm) | 15.6591 |
|---|---|
| Estimated P/E(12/2013) | 11.8587 |
| Relative P/E vs. KOSPI | 0.6021 |
| Earnings Per Share (KRW) (ttm) | 2,018.0000 |
| Est. EPS (KRW) (12/2013) | 2,664.7050 |
| Est. PEG Ratio | - |
| Market Cap (M KRW) | 3,173,983.50 |
| Shares Outstanding (M) | 100.44 |
| 30 Day Average Volume | 4,242,018 |
| Price/Book (mrq) | 2.6004 |
| Price/Sale (ttm) | 7.8002 |
| Dividend Indicated Gross Yield | 0.08% |
| Cash Dividend (KRW) | 26.0870 |
| Last Dividend | 12/27/2012 |
| 5 Year Dividend Growth | -14.76% |
| Next Earnings Announcement | 02/19/2014 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for 068270
Company Profile & Key Executives for 068270
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment.
| Seo Jung-JinChairman/CEO/Rep Director | Park Seong-DoVice Chairman |
| Gi U-SeongSenior Vice President | Hong Seung-SeoSenior Vice President |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
068270 News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page